IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by de Rojas
Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism
1. Fundació ACE, Barcelona, Spain 2. Universitat de Barcelona Facultat de Farmacia i Ciencies de l'Alimentacio, Barcelona, Spain 3. Universite du Luxembourg Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg 4. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain 5. Fundacion Centro de Investigacion de Enfermedades Neurologicas, Madrid, Spain 6. Universidade de Santiago de Compostela, Santiago de Compostela, Spain 7.
Listening for Alzheimer’s clues: machine learning analysis of multidomain speech features for cognitive impairment screening
Abstract Introduction: Early detection of Alzheimer’s disease (AD) is critical for timely intervention, particularly during the mild cognitive impairment (MCI) stage. This study aimed to develop and evaluate a multidomain speech analysis framework to support cognitive screening, biomarker prediction within the amyloid, tau and neurodegeneration (ATN) framework, and estimation of cognitive function across the AD continuum.
Machine learning in Alzheimer's disease genetics
Hyppää sisältöön Bracher-Smith, Matthew; Melograna, Federico; Ulm, Brittany; Bellenguez, Celine; Grenier-Boley, Benjamin; Duroux, Diane; Nevado, Alejo J.; Holmans, Peter; Tijms, Betty M.; Hulsman, Marc; de Rojas, Itziar; Campos-Martin, Rafael; van der Lee, Sven; Castillo, Atahualpa; Kucukali, Fahri; Peters, Oliver; Schneider, Anja; Dichgans, Martin; Rujescu, Dan; Scherbaum, Norbert; Deckert, Juergen; Riedel-Heller, Steffi; Hausner, Lucrezia; Molina-Porcel, Laura; Duezel, Emrah; Grimmer, Timo;...
Genetic testing of common and rare variants in dementia patients from a memory clinic - Alzheimer's Research & Therapy
References 2023 Alzheimer’s disease facts and figures. Alzheimers Dement 19, 1598–1695 (2023). Campion D, et al. Early-onset autosomal dominant alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65:664–70. Article CAS PubMed PubMed Central Google Scholar Sherrington R, et al. Cloning of a gene bearing missense mutations in early-onset Familial alzheimer’s disease. Nature. 1995;375:754–60. Article CAS PubMed Google Scholar Rogaev EI, et al.
Extra-virgin olive oil and additional cardiovascular outcomes in the PREDIMED Trial: An outcome-wide perspective
BACKGROUND: Olive oil, increasingly consumed in the U.S., has been inversely associated with cardiovascular disease (CVD) risk. However, previous studies did not assess a broad spectrum of CVD outcomes, incorporated repeated annual dietary assessments, or distinguished between polyphenol-rich EVOO and common olive oil (COO), which lacks these compounds. METHODS: We assessed 7102 high-risk participants from the PREDIMED trial (57.5% women; aged 55-80 years), all free of CVD at baseline.
A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC - European Journal of Human Genetics
Abstract Progressive supranuclear palsy (PSP) is a rare 4-repeat tauopathy that causes behavioural, movement and cognitive abnormalities. We genotyped all available clinical and histopathological PSP cases in Spain and Portugal (N = 522), and conducted the largest PSP GWAS of the Iberian population to date. Genetic burden analysis revealed reduced diagnostic specificity in clinically diagnosed atypical PSP cases—when applying the 2017 MDS criteria—compared to Richardson’s syndrome cases.
Utility of 28S Ribosomal RNA Gene Domains for Molecular Classification and Phylogeny of Rhinonyssid Mites
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Exploring sex differences in Alzheimer’s disease: a comprehensive analysis of a large patient cohort from a memory unit - Alzheimer's Research & Therapy
The study cohort consisted of 6108 individuals diagnosed with AD dementia during the study period (Table 1), with 1735 (28.4%) males and 4373 (71.6%) females. The ML algorithm selected the covariates that were more closely related to patients’ sex. These ML models demonstrated an average accuracy of 74.9% in differentiating between males and females over the test set, assessed through ten repetitions of five-fold cross-validation.
'Goteras' llega a Torrejón, Alcorcón y Velilla de San Antonio
La comedia de ciencia ficción ‘Goteras’ se presenta el sábado, 11 de enero, en el Teatro Municipal José María Rodero de Torrejón de Ardoz, el viernes, 31 de enero, en el Teatro Buero Vallejo de Alcorcón y el sábado, 1 de febrero, en el Auditorio Mariana Pineda de Velilla de San Antonio. Mic Producciones y Producciones 099 han creado esta obra humorística en la que un joven descubre que su vecino es él mismo 30 años mayor. Y está protagonizada por Fernando Albizu y Gonzalo Ramos.
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort - Alzheimer's Research & Therapy
This study derives from the NORFACE project, established in 2014 at Ace Alzheimer Center Barcelona (Ace) with the goal to investigate retinal biomarkers in AD using OCT imaging [28,29,30]. The current work was designed as a cross-sectional observational study using data from a large cohort of consecutive patients evaluated due to cognitive decline at Ace between June 2016 and March 2019.
Identification of a specific APOE transcript and functional elements associated with Alzheimer’s disease - Molecular Neurodegeneration
Reardon S. FDA approves Alzheimer’s drug lecanemab amid safety concerns. Nature. 2023;613:227–8. CAS PubMed Google Scholar Alzheimer’s_Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2018;2018:367–429. Google Scholar Rajan KB, Weuve J, Barnes LL, Wilson RS, Evans DA. Prevalence and incidence of clinically diagnosed Alzheimer’s disease dementia from 1994 to 2012 in a population study. Alzheimers Dement. 2019;15:1–7.
Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment - Alzheimer's Research & Therapy
Study populations Study participants included in the analyses came from two cohorts of the Alzheimer's Disease Apolipoprotein Pathology for Treatment Elucidation and Development (ADAPTED) consortium, including Barcelona-based memory clinic Ace Alzheimer Center Barcelona (147 CSF-plasma paired samples) and Heidelberg/Mannheim memory clinic (58 CSF samples). Demographic information of the full data set is provided in Supplementary Table 1.
Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment - Alzheimer's Research & Therapy
Abstract Isoprostanes and prostaglandins are biomarkers for oxidative stress and inflammation. Their role in Alzheimer's disease (AD) pathophysiology is yet unknown. In the current study, we aim to identify the association of isoprostanes and prostaglandins with the Amyloid, Tau, Neurodegeneration (ATN) biomarkers (Aβ-42, p-tau, and t-tau) of AD pathophysiology in mild cognitive impairment (MCI) subjects.
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort - Alzheimer's Research & Therapy
The Neuro-Ophthalmology Research at Fundació ACE (NORFACE) cohort was founded in 2014 to investigate retinal biomarkers of AD and examine the relationship between retinal changes and different types of neurodegenerative disorders [20]. In the present study, we included non-demented participants from the FACEHBI [21] and BIOFACE [22] research cohorts at Ace Alzheimer Center Barcelona with a diagnosis of either Subjective Cognitive Decline (SCD) [23] or MCI [24].
Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort - Alzheimer's Research & Therapy
The study population comprised 3170 participants from the Neuro-Ophthalmology Research at Fundació ACE (NORFACE) cohort, which was founded in 2014 to search for retinal biomarkers of AD and examine the relationships between retinal changes and different types of neurodegenerative disorders [12].
Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum - Alzheimer's Research & Therapy
This study comprised 1500 individuals who underwent evaluation at the Memory Clinic of Ace Alzheimer Center Barcelona (Ace) (single site) between March 2022 and April 2023. The participants were referred to the Memory Clinic either by their General Health practitioner due to subjective cognitive complaints, or they attended the Open House Initiative without a previous referral from a physician [33]. All subjects completed neurological, neuropsychological, and social evaluations at Ace.
Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment
1. Introduction Alzheimer's disease (AD) stands as the primary contributor to dementia cases worldwide, with no effective treatment available (Alzheimer's & Dementia, 2023). This progressive neurodegenerative disease impacts different cognitive domains, including memory, language, attention, and behavior, ultimately incapacitating the individual from performing daily tasks (Alzheimer's & Dementia, 2023).
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
Scientific Reports, Apr 2023 This is a preview of a remote PDF: https://www.nature.com/articles/s41598-023-32515-6.pdf Morató, Xavier, Marquié, Marta, Tartari, Juan Pablo, Lafuente, Asunción, Abdelnour, Carla, Alegret, Montserrat, Jofresa, Sara, Buendía, Mar, Pancho, Ana, Aguilera, Núria, Ibarria, Marta, Diego, Susana, Cuevas, Rosario, Cañada, Laia, Calvet, Anna, Antonio, Ester Esteban-De, Pérez-Cordón, Alba, Sanabria, Ángela, de Rojas, Itziar, Nuñez-Llaves, Raúl, Cano, Amanda, Orellana,...
Frontiers | Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer´s disease in individuals with mild cognitive impairment: the NORFACE cohort
Marta Marquié1, 2*, Ainhoa García-Sánchez1, Emilio Alarcón-Martín1, Joan Martínez1, Miguel Castilla-Martí3, 4, Luis Castilla-Martí5, 6, Adelina Orellana1, 2, Laura Montrreal1, Itziar de Rojas1, 2, Pablo García-González1, 2, Raquel Puerta1, Clàudia Olivé1, Amanda Cano1, 2, Isabel Hernández1, Maitee Rosende-Roca1, Liliana Vargas1, Juan Pablo Tartari1, Ester Esteban-De Antonio1, Urszula Bojaryn1, Mario Ricciardi1, Diana M.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with de
Contact de, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack